Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
C. Molik-Oeser, S. Tahanovich, O. Schroeder, S. Hammerschmidt, R. Genzel, M. Syhre, H. Wirtz (Leipzig, Borsdorf, Germany). Discriminating NSCLC from COPD using patterns derived from an electronic nose. Eur Respir J 2011; 38: Suppl. 55, 2792

Member's Comments

No comment yet.

Related content which might interest you: An electronic nose in the discrimination of patients with lung cancer and controls Source: Annual Congress 2012 - Early detection of lung cancer Year: 2012 Detecting subtypes of non-small cell lung cancer by electronic nose. Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018 Differentiation of asthma and COPD by electronic nose Source: Annual Congress 2010 - Advances in lung function II Year: 2010 The electronic nose: emerging biomarkers in lung cancer diagnostics Source: Breathe, 15 (4) e135; 10.1183/20734735.0309-2019 Year: 2019 Relevant and redundant lung function parameters in discriminating asthma from COPD Source: Eur Respir J 2005; 26: Suppl. 49, 362s Year: 2005 Detection of non-small cell lung cancer by an electronic nose. Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 Identification of recent exacerbations in COPD patients by electronic nose Source: ERJ Open Res, 6 (4) 00307-2020; 10.1183/23120541.00307-2020 Year: 2020 Early detection of lung cancer in patients with COPD by eNose technology Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018 Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 An electronic nose distinguishes the exhaled breath condensates of patient groups with COPD, alpha-1-antitrypsin deficiency and healthy controls Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Prevalence and clinical characteristics of lung cancer with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 321s Year: 2005 Classification ability of two electronic noses in asthma and COPD Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 An electronic nose distinguishes the exhaled breath condensates of AATD patients and healthy controls Source: Annual Congress 2008 - New frontiers in noninvasive assessment of the lungs Year: 2008 Detection of small cell lung cancer by electronic nose. Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018 Analysis and comparison of the transcriptome of COPD patients with and without lung cancer Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Clinical feature of elderly patients with lung cancer and COPD Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer Year: 2009 Gene expression signatures in airway and nasal epithelium of COPD: linking endotypes to clinical outcomes Source: International Congress 2017 – Heterogeneity in COPD inflammation: implications for therapy and clinical outcomes Year: 2017 Sources of origin of the oropharyngeal microbiota in patients with different phenotypes of COPD Source: International Congress 2017 – COPD management: new findings from large studies Year: 2017 An electronic nose can distinguish between different asthma phenotypes Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Airway dimensions in COPD patients: Relationship with lung functions Source: Annual Congress 2011 - Morphological and functional imaging in obstructive airway disease Year: 2011